Boniva 3 mg 3 ml syringe
Date of first authorisation: Many things put people at risk for osteoporosis.
Clinically relevant reductions in serum levels of calcium, phosphorusand magnesium should be corrected by intravenous administration of calcium gluconate, potassium or sodium phosphate, and magnesium sulfaterespectively.
BONIVA ibandronate sodium is a nitrogen -containing bisphosphonate that inhibits osteoclast -mediated bone resorption. Symptoms consistent with acute phase reaction APR have been reported with intravenous bisphosphonate use. Atypical fractures of the femur.
Relative risk reduction of clinical vertebral fracture. Intravenous overdosage may result in hypocalcemia, hypophosphatemia, and hypomagnesemia. In lactating rats treated with intravenous doses of 0. Do not share this medication with others. Rarely, patients taking bisphosphonates have reported serious jaw problems associated with delayed healing and infection, often following dental procedures such as tooth extraction.
The incidence of serious adverse reactions was 8. List Boniva Syringe side effects by likelihood and severity. If you miss a dose, reschedule with your health care professional as soon as possible.
Weak bones are more likely to break. Last reviewed on RxList: Pharmacokinetics in special clinical situations Gender Pharmacokinetics of ibandronic acid are similar in men and women. You are encouraged to report negative side effects of prescription drugs to the FDA.
Company contact details
At two years, There is limited data available on patients of African origin. Marketing authorisation holder 8. Remember to receive it every 3 months. The two treatment groups were also similar with regard to the number of fractures reported at the individual non-vertebral sites: The recommended dose of ibandronic acid is 3 mg, administered as an intravenous injection over 15 - 30 seconds, every three months.
Most patients had relief of symptoms after stopping the bisphosphonate. Ocular inflammation events such as uveitis, episcleritis and scleritis have been reported with ibandronic acid. After BONIVA Injection, assess renal function, as clinically appropriate, in patients with concomitant diseases or taking medications that have the potential for adverse effects on the kidney.
This medicinal product does not require any special storage conditions.
Incidence of new morphometric vertebral fractures. General Disorders and Administration Site Conditions.